These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21777551)

  • 1. Trismus following treatment of head and neck cancer.
    Jeremic G; Venkatesan V; Hallock A; Scott D; Hammond A; Read N; Franklin J; Yoo J; Fung K
    J Otolaryngol Head Neck Surg; 2011 Aug; 40(4):323-9. PubMed ID: 21777551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trismus in head and neck cancer patients in Sweden: incidence and risk factors.
    Johnson J; van As-Brooks CJ; Fagerberg-Mohlin B; Finizia C
    Med Sci Monit; 2010 Jun; 16(6):CR278-82. PubMed ID: 20512090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced trismus in the ARTSCAN head and neck trial.
    Lindblom U; Gärskog O; Kjellén E; Laurell G; Levring Jäghagen E; Wahlberg P; Zackrisson B; Nilsson P
    Acta Oncol; 2014 May; 53(5):620-7. PubMed ID: 24669774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouth opening and trismus in patients undergoing curative treatment for head and neck cancer.
    Steiner F; Evans J; Marsh R; Rigby P; James S; Sutherland K; Wickens R; Nedev N; Kelly B; Tan ST
    Int J Oral Maxillofac Surg; 2015 Mar; 44(3):292-6. PubMed ID: 25577664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer.
    Pauli N; Johnson J; Finizia C; Andréll P
    Acta Oncol; 2013 Aug; 52(6):1137-45. PubMed ID: 23193958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer.
    Rao SD; Saleh ZH; Setton J; Tam M; McBride SM; Riaz N; Deasy JO; Lee NY
    Acta Oncol; 2016; 55(1):99-104. PubMed ID: 25920361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer.
    Kraaijenga SA; Oskam IM; van der Molen L; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Oral Oncol; 2015 Aug; 51(8):787-94. PubMed ID: 26027851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures.
    van der Molen L; Heemsbergen WD; de Jong R; van Rossum MA; Smeele LE; Rasch CR; Hilgers FJ
    Radiother Oncol; 2013 Mar; 106(3):364-9. PubMed ID: 23540551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus.
    Teguh DN; Levendag PC; Voet P; van der Est H; Noever I; de Kruijf W; van Rooij P; Schmitz PI; Heijmen BJ
    Head Neck; 2008 May; 30(5):622-30. PubMed ID: 18213726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-volume analysis of radiation-induced trismus in head and neck cancer patients.
    Gebre-Medhin M; Haghanegi M; Robért L; Kjellén E; Nilsson P
    Acta Oncol; 2016 Nov; 55(11):1313-1317. PubMed ID: 27595312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary report on the efficacy of a dynamic jaw opening device (dynasplint trismus system) as part of the multimodal treatment of trismus in patients with head and neck cancer.
    Stubblefield MD; Manfield L; Riedel ER
    Arch Phys Med Rehabil; 2010 Aug; 91(8):1278-82. PubMed ID: 20684911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Kraaijenga SA; Hamming-Vrieze O; Verheijen S; Lamers E; van der Molen L; Hilgers FJ; van den Brekel MW; Heemsbergen WD
    Head Neck; 2019 May; 41(5):1387-1394. PubMed ID: 30652390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.
    Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
    Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
    Caudell JJ; Schaner PE; Meredith RF; Locher JL; Nabell LM; Carroll WR; Magnuson JS; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):410-5. PubMed ID: 18635320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy.
    Faravel K; Jarlier M; Senesse P; Huteau ME; Janiszewski C; Stoebner A; Boisselier P
    Integr Cancer Ther; 2023; 22():15347354221147283. PubMed ID: 36625502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
    Bernier J; Domenge C; Ozsahin M; Matuszewska K; Lefèbvre JL; Greiner RH; Giralt J; Maingon P; Rolland F; Bolla M; Cognetti F; Bourhis J; Kirkpatrick A; van Glabbeke M;
    N Engl J Med; 2004 May; 350(19):1945-52. PubMed ID: 15128894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic.
    Rütten H; Pop LA; Janssens GO; Takes RP; Knuijt S; Rooijakkers AF; van den Berg M; Merkx MA; van Herpen CM; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):923-9. PubMed ID: 21095074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise therapy for trismus in head and neck cancer.
    Dijkstra PU; Sterken MW; Pater R; Spijkervet FK; Roodenburg JL
    Oral Oncol; 2007 Apr; 43(4):389-94. PubMed ID: 16979926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective assessment of trismus in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT).
    Owosho AA; Pedreira Ramalho LM; Rosenberg HI; Yom SK; Drill E; Riedel E; Tsai CJ; Lee NY; Huryn JM; Estilo CL
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1408-13. PubMed ID: 27377999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
    Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.